ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,376 | +26.2% | 2,753 | +22.4% | 0.00% | – |
| Q2 2023 | $44,668 | +30.5% | 2,249 | +12.5% | 0.00% | – |
| Q1 2023 | $34,224 | -9.4% | 1,999 | +4.0% | 0.00% | – |
| Q4 2022 | $37,795 | +1159.8% | 1,923 | +861.5% | 0.00% | – |
| Q3 2022 | $3,000 | -25.0% | 200 | -18.4% | 0.00% | – |
| Q2 2022 | $4,000 | 0.0% | 245 | -14.6% | 0.00% | – |
| Q1 2022 | $4,000 | -33.3% | 287 | -7.1% | 0.00% | – |
| Q4 2021 | $6,000 | -25.0% | 309 | +12.0% | 0.00% | – |
| Q3 2021 | $8,000 | -33.3% | 276 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | -25.0% | 276 | -26.2% | 0.00% | – |
| Q1 2021 | $16,000 | +23.1% | 374 | +61.9% | 0.00% | – |
| Q4 2020 | $13,000 | +1200.0% | 231 | +645.2% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 31 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 31 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 31 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,037,486 | $280,250,000 | 19.13% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $52,015,000 | 9.58% |
| Boxer Capital, LLC | 1,466,051 | $25,715,000 | 2.97% |
| Ghost Tree Capital, LLC | 600,000 | $10,524,000 | 2.75% |
| BRIDGER MANAGEMENT, LLC | 1,529,032 | $26,819,000 | 2.12% |
| Cormorant Asset Management, LP | 1,700,000 | $29,818,000 | 2.02% |
| EcoR1 Capital, LLC | 450,000 | $7,893,000 | 0.73% |
| UNIVERSITY OF NOTRE DAME DU LAC | 171,015 | $3,000,000 | 0.67% |
| Virtus ETF Advisers LLC | 17,799 | $312,000 | 0.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 290,001 | $5,087,000 | 0.46% |